NBPDP Formulary Update

Similar documents
Product Selection Committee / Comité de sélection des produits

NB Drug Plans Formulary Update

NBPDP Formulary Update

NBPDP Formulary Update

Product Selection Committee / Comité de sélection des produits

NB Drug Plans Formulary Update

A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS. Pan-Canadian Select Molecule Price Initiative for Generic Drugs

NB Drug Plans Formulary Update

New Interchangeable Products Approved and Benefit Status Within the Nova Scotia Pharmacare Programs March 2016

BULLETIN # 101. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 18, 2018

BULLETIN # 74. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 17, 2013

NB Drug Plans Formulary Update

BULLETIN # 70. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 21, 2013

BULLETIN # 73. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on July 17, 2013

NB Drug Plans Formulary Update

ANNOUNCEMENT. Dear Valued Customer:

ASEBP and ARTA TARP Drugs and Reference Price by Categories

BULLETIN # 78. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on July 17, 2014

UPDATE AF Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective March 26, 2012 SUMMARY OF CHANGES

BULLETIN # 84. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 22, 2015

Updates to the Alberta Drug Benefit List. Effective September 1, 2018

Table 1: Price increases for Brand Name Drugs with Generic Equivalents

Ontario Drug Benefit Formulary/Comparative Drug Index

BULLETIN # 72. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on April 18, 2013

2018 Step Therapy Criteria

Ontario Drug Benefit Formulary/Comparative Drug Index

CLAIM SUBMISSION QUANTITIES

BULLETIN # 79. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 16, 2014

Nova Scotia Pharmacare Programs Interchangeable Product Updates November 13, 2018 New Categories

Ontario Drug Benefit Formulary/ Comparative Drug Index

UPDATE AX Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective August 29, 2013 SUMMARY OF CHANGES

Updates to the Alberta Drug Benefit List. Effective November 1, 2018

Updates to the Alberta Health and Wellness Drug Benefit List

BULLETIN # 90. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 25, 2017

Alaska Medicaid 90 Day** Generic Prescription Medication List

Manager, PEI Drug Programs Date : December 7, 2009 Tel / Tél : (902) Fax / Téléc : (902)

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 759 M %

Updates to the Alberta Drug Benefit List. Effective February 1, 2018

Ontario Drug Benefit Formulary/Comparative Drug Index

Archived Content. This content was archived on June 24, 2013.

Riesbeck's Pharmacy Reward Club Generic Medication List October 2017

Ontario Drug Benefit Formulary/Comparative Drug Index

NB Drug Plans Formulary Update

DT Description Price Category Price change

BULLETIN # 80. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 19, 2015

Published by the Pharmaceutical Services Division to provide information for British Columbia s health care providers

Ontario Drug Benefit Formulary/Comparative Drug Index

Riesbeck's Pharmacy Reward Club Generic Medication List February 2018 $4 30 Day Supply

SASKATCHEWAN FORMULARY BULLETIN Update to the 60th Edition of the Saskatchewan Formulary

Riesbeck's Pharmacy Reward Club Generic Medication List September 2017

Updates to the Alberta Drug Benefit List. Effective July 1, 2018

While there is around a 3% increase shown in costs for Category M lines, I think this is due to the inclusion of more lines in Category M.

UPDATE AU Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective May 31, 2013 SUMMARY OF CHANGES

Ontario Drug Benefit Formulary/Comparative Drug Index

ATYPICAL ANTIPSYCHOTICS

PRODUCT LIST June 2018

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

UPDATE AJ Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective July 27, 2012 SUMMARY OF CHANGES

UPDATE AB Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 25, 2011 SUMMARY OF CHANGES

SASKATCHEWAN FORMULARY COMMITTEE BULLETIN TO THE 58th EDITION OF THE SASKATCHEWAN FORMULARY

Innovative Products Available. OTC Products Available

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

DRUG CLASSIFICATION. Prevention of Cardiovascular Disease

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 702 M %

Summary of Changes to the Alberta Health and Wellness Drug Benefit List

Ontario Drug Benefit Formulary/Comparative Drug Index

SASKATCHEWAN FORMULARY COMMITTEE BULLETIN FOR THE UPDATE TO THE 56th EDITION OF THE SASKATCHEWAN FORMULARY

Ontario Drug Benefit Formulary/ Comparative Drug Index

UPDATE B Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 01, 2008 SUMMARY OF CHANGES

ACEBUTOLOL HCL 100MG TABLET GENERIC BETA BLOCKERS ALISKIREN 150MG TABLET RASILAZ RENIN INHIBITOR

QTY LIMIT COPAY (30 DAY/90 DAY) BENIGN PROSTATIC HYPERPLASIA FINASTERIDE $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8

DT Description Price Category Price change Percentage

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

BULLETIN # 102. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 24, 2019

COMMERCIAL APIs. S. No Molecule Name Therapeutic Category USDMF EDMF CEP IH

Ontario Drug Benefit Formulary/Comparative Drug Index

NBPDP FORMULARY UPDATE

Therapeutic Substitution Service - Proton Pump Inhibitors (PPIs)

Ambetter 90-Day-Supply Maintenance Drug List

Generic Preventive Care/ Safe Harbor Drug Program List

Ontario Drug Benefit Formulary/Comparative Drug Index

SASKATCHEWAN FORMULARY BULLETIN. Update to the 60th Edition of the Saskatchewan Formulary

Glossary of Medications

UPDATE AA Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective September 15, 2011 SUMMARY OF CHANGES

20:00. Blood Formulation, Coagulation and Thrombosis. 20:00 Blood Formulation, Coagulation and Thrombosis

Archived Content. This content was archived on June 24, 2013.

Ontario Drug Benefit Formulary/Comparative Drug Index

Pharmacy Savings Program

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM

BENEFIT CHANGES TO NBPDP

Non-Insured Health Benefits

Guide to the Modernized Reference Drug Program

Product Name Strength Dosage Form Therapeutic Area Dossier Status. Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved

New Exception Status Benefits

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

BULLETIN # 98. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on April 19, 2018

Transcription:

Bulletin # 830 April 4, 2012 NBPDP Formulary Update Please find attached lists of interchangeable product additions to the New Brunswick Prescription Drug Program Formulary and non-listed products subject to a Maximum Allowable Price (). Claims for products that are reimbursed at Actual Acquisition Cost () up to May 1, 2012 will be subject to a effective May 2, 2012. Please note: Hard copy versions of NBPDP Formulary Updates of interchangeable product additions will no longer be distributed. An electronic version is available on NBPDP webpage http://www.gnb.ca/0212/benefitupdates-e.asp To unsubscribe from the NBPDP emailed announcements, please send a message to info@nbpdp-pmonb.ca. The Updates are available on the NBPDP webpage: http://www.gnb.ca/0212/benefitupdates-e.asp

Amlodipine Besylate Bésylate d'amlodipine Tab Orl 2.5mg Jamp-Amlodipine 2357186 JPC AEFVW 5mg Jamp-Amlodipine 2357194 JPC AEFVW 10mg Jamp-Amlodipine 2357208 JPC AEFVW Bisoprolol Fumarate Fumarate de bisoprolol Tab Orl 5mg Ava-Bisoprolol 2363887 AVA AEFVW 10mg Ava-Bisoprolol 2363895 AVA AEFVW Clindamycin Hydrochloride Clindamycine (chlorhydrate de) Cap Orl 150mg Ava-Clindamycin 2364719 AVA ABEFGVW 300mg Ava-Clindamycin 2364727 AVA ABEFGVW Diltiazem Hydrochloride Diltiazem (chlorhydrate de) ERC Orl 120mg Co-Diltiazem T 2370441 COB AEFVW Cap. L.P. 180mg Co-Diltiazem T 2370492 COB AEFVW 240mg Co-Diltiazem T 2370506 COB AEFVW 300mg Co-Diltiazem T 2370514 COB AEFVW 360mg Co-Diltiazem T 2370522 COB AEFVW Domperidone Maleate Dompéridone (maléate de) Tab Orl 10mg Ava-Domperidone 2364271 AVA Entacapone Tab Orl 200mg Teva-Entacapone 2375559 TEV Spec. Auth. 0.8020 Famciclovir Tab Orl 125mg Ava-Famciclovir 2366827 AVA 250mg Ava-Famciclovir 2366835 AVA 500mg Ava-Famciclovir 2366843 AVA Fenofibrate Fénofibrate Tab Orl 100mg Fenofibrate-S 2356570 SAS 160mg Fenofibrate-S 2356589 SAS Page 1 April/Avril 2012

Finasteride Finastéride Tab Orl 5mg Apo-Finasteride 2365383 APX Spec.Auth. Furosemide Furosémide Tab Orl 20mg Ava-Furosemide 2364573 AVA 40mg Ava-Furosemide 2364581 AVA 80mg Ava-Furosemide 2364603 AVA Gliclazide Tab Orl 80mg Ava-Gliclazide 2363518 AVA ABEFGVW Hydromorphone Hydrochloride Hydromorphone (chlorhydrate d') Tab Orl 1mg Teva-Hydromorphone 2319403 TEV 2mg Teva-Hydromorphone 2319411 TEV 4mg Teva-Hydromorphone 2319438 TEV 8mg Teva-Hydromorphone 2319446 TEV Irbesartan Tab Orl 75mg Irbesartan 2372347 SAS Mylan-Irbesartan 2347296 MYL 150mg Irbesartan 2372371 SAS Mylan-Irbesartan 2347318 MYL 300mg Irbesartan 2372398 SAS Mylan-Irbesartan 2347326 MYL Irbesartan/Hydrochlorothiazide Tab Orl 150mg/12.5mg Irbesartan/HCTZ 2372886 SAS 300mg/12.5mg Irbesartan/HCTZ 2372894 SAS 300mg/25mg Irbesartan/HCTZ 2372908 SAS Levofloxacin Lévofloxacine Tab Orl 250mg Ava-Levofloxacin 2361027 AVA VW & Spec.Auth. 500mg Ava-Levofloxacin 2361035 AVA VW & Spec.Auth. Lisinopril Tab Orl 5mg Jamp-Lisinopril 2361531 JPC 10mg Jamp-Lisinopril 2361558 JPC 20mg Jamp-Lisinopril 2361566 JPC Page 2 April/Avril 2012

Losartan Potassium Losartan potassique Tab Orl 25mg Apo-Losartan 2379058 APX Meloxicam Tab Orl 7.5mg Ava-Meloxicam 2365545 AVA 15mg Ava-Meloxicam 2365553 AVA Metformin Hydrochloride Metformine (chlorhydrate de) Tab Orl 500mg Ava-Metformin 2364506 AVA 850mg Ava-Metformin 2364514 AVA Metoprolol Tartrate Métoprolol (tartrate de) Tab Orl 25mg Jamp-Metoprolol-L 2356813 JPC 0.0611 50mg Jamp-Metoprolol-L 2356821 JPC 0.1164 100mg Jamp-Metoprolol-L 2356848 JPC 0.2112 Mycophenolate Mofetil Mycophénolate Mofétil Tab Orl 500mg Co-Mycophenolate 2379996 COB R Nabilone Cap Orl 0.5mg pms-nabilone 2380900 PMS Caps Ran-Nabilone 2358085 RAN Spec. Auth. 1.5513 1mg pms-nabilone 2380919 PMS Ran-Nabilone 2358093 RAN Spec. Auth. 3.1025 Olanzapine Tab Orl 2.5mg Olanzapine 2372819 SAS W & Spec. Auth. 5mg Olanzapine 2372827 SAS W & Spec. Auth. 7.5mg Olanzapine 2372835 SAS W & Spec. Auth. 10mg Olanzapine 2372843 SAS W & Spec. Auth. 15mg Olanzapine 2372851 SAS W & Spec. Auth. Omeprazole Oméprazole SRT Orl 20mg Ran-Omeprazole 2374870 RAN ABEFGVW L.L. Oxycodone Hydrochloride/Acetaminophen Oxycodone (chlorhydrate d')/acétaminophène Tab Orl 5mg/325mg Oxycodone/Acet 2361361 SAS Page 3 April/Avril 2012

Pantoprazole Sodium Pantoprazole sodique ECT Orl 40mg Pantoprazole 2370808 SAS Spec. Auth. Ent. Rabeprazole Sodium Rabéprazole sodique ECT Orl 10mg Apo-Rabeprazole 2345579 APX ABEFGVW Ent. 20mg Apo-Rabeprazole 2345587 APX ABEFGVW Ramipril Cap Orl 2.5mg Ramipril 2374846 SAS 5mg Ramipril 2374854 SAS 10mg Ramipril 2374862 SAS Rosuvastatin Calcium Rosuvastatin calcique Tab Orl 10mg Apo-Rosuvastatin 2337983 APX Co-Rosuvastatin 2339773 COB Mylan-Rosuvastatin 2381273 MYL pms-rosuvastatin 2378531 PMS Ran-Rosuvastatin 2382652 RAN Sandoz Rosuvastatin 2338734 SDZ Teva-Rosuvastatin 2354616 TEV AEFVW 0.6800 20mg Apo-Rosuvastatin 2337991 APX Co-Rosuvastatin 2339781 COB Mylan-Rosuvastatin 2381281 MYL pms-rosuvastatin 2378558 PMS Ran-Rosuvastatin 2382660 RAN Sandoz Rosuvastatin 2338742 SDZ Teva-Rosuvastatin 2354624 TEV AEFVW 0.8500 40mg Apo-Rosuvastatin 2338009 APX Co-Rosuvastatin 2339803 COB Mylan-Rosuvastatin 2381303 MYL pms-rosuvastatin 2378566 PMS Ran-Rosuvastatin 2382679 RAN Sandoz Rosuvastatin 2338750 SDZ Teva-Rosuvastatin 2354632 TEV AEFVW 0.9950 Sertraline Hydrochloride Sertraline (chlorhydrate de) Cap Orl 25mg Ran-Sertraline 2374552 RAN 50mg Ran-Sertraline 2374560 RAN 100mg Ran-Sertraline 2374579 RAN Page 4 April/Avril 2012

Simvastatin Simvastatine Tab Orl 5mg Mar-Simvastatin 2375036 MAR 10mg Mar-Simvastatin 2375044 MAR 20mg Mar-Simvastatin 2375052 MAR 40mg Mar-Simvastatin 2375060 MAR 80mg Mar-Simvastatin 2375079 MAR Sotalol Hydrochloride Sotalol (chlorhydrate de) Tab Orl 80mg Ava-Sotalol 2363674 AVA 160mg Ava-Sotalol 2363682 AVA Sumatriptan Tab Orl 50mg Ava-Sumatriptan 2366258 AVA Spec. Auth. 100mg Ava-Sumatriptan 2366266 AVA Spec. Auth. Telmisartan/Hydrochlorothiazide Tab Orl 80mg/12.5mg Teva-Telmisartan HCTZ 2330288 TEV 80mg/25mg Teva-Telmisartan HCTZ 2379252 TEV Valsartan Tab Orl 80mg Ava-Valsartan 2367122 AVA 160mg Ava-Valsartan 2367130 AVA 320mg Ava-Valsartan 2367149 AVA Valsartan/Hydrochlorothiazide Tab Orl 80mg/12.5mg Ava-Valsartan HCT 2367068 AVA 160mg/12.5mg Ava-Valsartan HCT 2367076 AVA 160mg/25mg Ava-Valsartan HCT 2367084 AVA 320mg/12.5mg Ava-Valsartan HCT 2367092 AVA 320mg/25mg Ava-Valsartan HCT 2367106 AVA Venlafaxine Hydrochloride Venlafaxine (chlorhydrate de) SRC Orl 37.5mg GD-Venlafaxine XR 2360020 GMD Cap.L.L. Ran-Venlafaxine XR 2380072 RAN 75mg GD-Venlafaxine XR 2360039 GMD Ran-Venlafaxine XR 2380080 RAN 150mg GD-Venlafaxine XR 2360047 GMD Ran-Venlafaxine XR 2380099 RAN Page 5 April/Avril 2012

Zopiclone Tab Orl 5mg Ava-Zopiclone 2363534 AVA AEFVW 7.5mg Ava-Zopiclone 2363542 AVA AEFVW NON-LISTED PRODUCTS SUBJECT TO / PRODUITS NE FIGURANT PAS SUR LA LISTE ASSUJETIS AUX PAM Atomoxetine Hydrochloride Atomoxétine (chlorhydrate d') Cap Orl 18mg Mylan-Atomoxetine 2378930 MYL 25mg Mylan-Atomoxetine 2378949 MYL 40mg Mylan-Atomoxetine 2378957 MYL 60mg Mylan-Atomoxetine 2378965 MYL Esomeprazole Magnesium Trihydrate Esoméprazole magnésien trihydraté ERT Orl 20mg Apo-Esomeprazole 2339099 APX 1.8690 L.P. Rosuvastatin Calcium Rosuvastatin calcique Tab Orl 5mg Apo-Rosuvastatin 2337975 APX Co-Rosuvastatin 2339765 COB Mylan-Rosuvastatin 2381265 MYL pms-rosuvastatin 2378523 PMS Ran-Rosuvastatin 2382644 RAN Sandoz Rosuvastatin 2338726 SDZ Teva-Rosuvastatin 2354608 TEV 0.6450 Valacyclovir Tab Orl 1000mg pms-valacyclovir 2381230 PMS Valsartan Tab Orl 40mg Ava-Valsartan 2367114 AVA Page 6 April/Avril 2012